Ashkan Shoamanesh: Thrilled to Be Leading The Global INTERCEPT Trial
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research and Care at McMaster University, reposted from Hamilton Health Sciences on LinkedIn:
”Thrilled to be leading the global INTERCEPT trial alongside Alexander Benz and PJ Devereaux.
This trial addresses a major unmet need in patients with stroke and atrial fibrillation who continue to face a cumulative 5-year risk of recurrent stroke of 20–25% despite best medical therapy, including anticoagulation.
The Vine carotid filter system from Javelin Medical is a simple yet sophisticated device designed to prevent the most disabling and life-threatening recurrent strokes in these patients.
The device is implanted percutaneously through a fine needle under ultrasound guidance and does not require anaesthesia.
We are now expanding the trial to ~200 sites across 20 countries and have been thrilled with the outstanding early performance at Hamilton Health Sciences under the leadership of Aristeidis Katsanos, Brian van Adel, and Bill Wang, with Hamilton Health Sciences being the first hospital to ever perform this procedure outside of Europe.”
Quoting Hamilton Health Sciences‘s post:
”Filters keep coffee fresh, water clean, and cars running smoothly.
Now, a team of Hamilton Health Sciences doctors and researchers are using that same concept to prevent strokes, by placing tiny filters in patients’ carotid arteries at each side of the neck to trap blood clots so they can’t reach the brain.
We’re the first hospital site in North America and most of the world to perform this innovative new procedure to investigate whether these tiny filters, called Vine carotid filters, can lower the number of strokes caused by large vessel blockages inside the brain.
Read more about this global, Phase 3 clinical trial is taking place through a partnership with a medical device company and our Hamilton General Hospital’s stroke and neuro-intervention teams.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation
-
Aug 21, 2026, 09:07Sujal Lohana: Building a Better Blood Donor–Seeker App
-
Aug 21, 2026, 08:55Robert Sidonio: Connecting Experts in Bleeding and Clotting Disorders